Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 319

The DOI matches its Crossref record; 305 of the 305 references it cites were found in a registry or an index.

Japanese Clinical Practice Guideline for Diabetes 2016

Open access
Haneda, Masakazu, Noda, Mitsuhiko, Origasa, Hideki, Noto, Hiroshi, Yabe, Daisuke, Fujita, Yukihiro, Goto, Atsushi, Kondo, Tatsuya, Araki, Eiichi·2018·Diabetology International

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s13340-018-0345-3

Cites

305 of 305 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 305 references

Research works printed but not linked: 25

  1. Nakagawa Y, Ishikawa Y, Watanabe K, et al. Impact of the duration of diabetes and frequency of counseling on the effectiveness of dietitian-led medical nutrition therapy in patients with type 2 diabetes. J Jpn Diabetes Soc. 2014;57:813–9 (in Japanese) (level 3).
  2. Iwakura T, Fujimoto K, Tahara Y, et al. A case of severe hypoglycemia induced by sitagliptin added to ongoing glimepiride therapy in patients with type 2 diabetes. J Jpn Diabetes Soc. 2010;53:505–8 (in Japanese, level 4).
  3. United Kingdom Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837–53 (level 1+). · DOI · Paper page
  4. Han A, Katoh S, Nemoto M, et al. Effect of combination therapy of premixtured 50 R and voglibose in patients with type 2 diabetes. J Jpn Diabetes Soc. 2004;47:137–40 (in Japanese, level 1).
  5. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977–86 (level 1). · DOI · Paper page
  6. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977–86 (level 1+). · DOI · Paper page
  7. United Kingdom Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837–53 (level 1+). · DOI · Paper page
  8. Soubrane G, Canivet J, Coscas G. Influence of pregnancy on the evolution of background retinopathy. Int Ophthalmol. 1985;8:249–55 (level 2). · doi:10.1007/bf00137653
  9. Ohkubo Y, Kishikawa H, Araki E, et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract. 1995;28:103–17 (level 1). · DOI · Paper page
  10. Kimura S, Inoguchi T, Yokomizo H, et al. Randomized comparison of pitavastatin and pravastatin treatment on the reduction of urinary albumin in patients with type 2 diabetic nephropathy. Diabetes Obes Metab. 2012;14:666–9 (level 1+). · doi:10.1111/j.1463-1326.2012.01566.x
  11. The Diabetes Control and Complications Trial (DCCT) Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977–86 (level 1+). · DOI · Paper page
  12. Ohkubo Y, Kishikawa H, Araki E, et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract. 1995;28:103–17 (level 1). · DOI · Paper page
  13. Japanese Study Group on Diabetic Neuropathy. Simplified diagnostic criteria and clinical staging of diabetic polyneuropathy. Peripheral Nerve. 2012;23:109–111
  14. Resnick HE, Carter EA, Lindsay R, et al. Relation of lower-extremity amputation to all-cause and cardiovascular disease mortality in American Indians: the Strong Heart Study. Diabetes Care. 2004;27:1286–93 (level 2). · doi:10.2337/diacare.27.6.1286
  15. Stratton IM, Adler A, Neil HAW, et al. Association of glycaemia with macrovascular and microvascular complications of type 2diabetes (UKPDS 35): prospective observational study. BMJ. 2000;321:405–12 (level 2). · DOI · Paper page
  16. Stratton IM, Adler AI, Neil HA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000;321:405–12 (level 2). · DOI · Paper page
  17. Committee on Diagnostic Criteria for Metabolic Syndrome. Metabolic syndrome: its definition and diagnostic criteria. J Jpn Soc Intern. 2005;94:794–9 (in Japanese).
  18. Chew EY, Mills JL, Metzger BE, et al. Metabolic control and progression of retinopathy. The Diabetes in Early Pregnancy Study. National Institute of Child Health and Human Development Diabetes in Early Pregnancy Study. Diabetes Care. 1995;18:631–7 (level 2). · DOI · Paper page
  19. Sanaka M,Minei S,Iwamoto Y. The allowance for pregnancy of women with diabetic nephropathy. J Jpn Soc Diabetes Pregnancy. 2006;6:127–35 (in Japanese, level 4).
  20. Hiramatsu Y, Haneda M, et al. The joint committee with the Japan Society of Diabetes and Pregnancy and the Japan Diabetes Society "An abnormal glucose metabolism during pregnancy and the standardization of its diagnostic criteria." J Jpn Diabetes Soc. 2015;58:801–803 (in Japanese)
  21. Sasai H, Sairenchi T, Irie F, et al. Development of a diabetes risk prediction sheet for specific health guidance. Nippon Koshu Eisei Zasshi. 2008;55:287–94 (in Japanese, level 3).
  22. Loke YK, Singh S, Furberg CD. Long-term use of thiazolidinediones and fractures in type 2 diabetes: a meta-analysis. CMAJ. 2009;180:32–39. · DOI · Paper page
  23. Kenmochi T, Asano T, Saigo K et al. The first case of simultaneous pancreas-kidney transplant from living donor in our country. Japanese J. of Transplant. 2005;40:466–472. (in Japanese)
  24. Fukao K, Otsuka M, Iwasaki H et al. A case of simultaneous whole pancreas and kidney allotransplantation. Japanese J. of Transplant. 1986;21:331–340. (in Japanese)
  25. The Japanese Pancreas and Islet Transplantation Association. Islet transplantation in Japan―Report from Japanese Islet Transplantation Registry―. Japanese J. of Transplant. 2014;49:292–297. (in Japanese).

Cited by

See all 319

Metadata

Authors
Haneda, M., Noda, M., Origasa, H., Noto, H., Yabe, D., Fujita, Y., Goto, A., Kondo, T., & Araki, E.
Venue
Diabetology International
Published
2018-02
Volume
9
Issue
1
Pages
1-45
ISSN
  • 2190-1678 (ISSN-L)
  • 2190-1686
OpenAlex
W2794676804
Cited by
319
References
305
FWCI
42.30
Type
journal article
Language
en
Open access
green
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Japanese Clinical Practice Guideline for Diabetes 2016. https://app.cochat.ai/papers/10.1007/s13340-018-0345-3
The paper
Haneda, M., Noda, M., Origasa, H., Noto, H., Yabe, D., Fujita, Y., Goto, A., Kondo, T., & Araki, E. (2018). Japanese Clinical Practice Guideline for Diabetes 2016. Diabetology International. https://doi.org/10.1007/s13340-018-0345-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.